Advancing Clinical Research.
ApoCell is a service provider recognized as a leader in biomarker research, with efforts focused on the identification and analysis of biomarkers and molecular profiling in rare circulating cells. Both standard and proprietary platforms are used to isolate and enrich cell populations of interest, especially circulating tumor cells (CTCs) and circulating epithelial cells (CECs), as well as additional rare cell types including stem cells.
Founded in 2004, the company has provided esoteric testing services to more than 80 pharmaceutical and biotechnology sponsor companies in over 120 clinical trials, in multiple therapeutic areas. Pre-clinical through Phase III clinical studies are currently supported with over 200 trial sites world-wide.
Therapeutic Areas